Table 2.

Exposures to, and deaths after, dihydroartemisinin–piperaquine

	Individuals	Courses	Doses	Deaths	Deaths within 30 days	Sudden unexplained deaths
Mass drug administration	154 505	432 001*	1 189 029	30	11	1
Preventive therapies and case management repeated courses	15 188	40 981*	122 943*	16	6	0
Case management single courses	28 174	28 174*	84 522*	15	14	0
Total	197 867	501 156	1 396 494	61	31	1

^*Derived from another denominator.